Page 26 - Pfizer

We didn't delay vaccine results until after US election, says Pfizer CEO

Last week, Pfizer and BioNTech said their vaccine was more than 90% effective at preventing Covid-19, based on an initial analysis

Decoded: Why the Moderna Covid-19 vaccine holds promise over Pfizer's

The Pfizer vaccine (more than 90 per cent effective) must be stored at minus 20 degrees Celsius. Creating cold chains to deliver this to billions is impossible in any reasonable time

Aviation and hotel stocks soar sharply on coronavirus vaccine hope

Shares of firms in the sectors have outperformed Sensex in November

Pfizer vaccine's -70 degree storage norm tough for most nations: V K Paul

Limited number of doses would not be enough to meet India's demand, adds Niti Aayog member

Pfizer, Moderna: How 2 firms sprinted ahead in the race for a Covid vaccine

Both companies have reported preliminary findings of more than 90% effectiveness - an unexpectedly high rate - raising hope for an end to the pandemic

Pfizer moves US court against Aurobindo Pharma, Dr Reddy's on cancer drug

Pfizer Inc alleged that the drug makers were planning separately to come out with generic versions of its blockbuster multi-billion dollar drug Ibrance (palbociclib) before expiration of its patent

World Coronavirus Dispatch: US stocks at new high over Moderna vaccine data

Hungary and Poland block EU stimulus package, Citi says successful vaccines will see dollar plummet, No virus protection for jailed elderly Taxes and other pandemic-related news across the globe

Britain expects to roll out Pfizer's Covid-19 vaccine before Christmas

"We're working very closely with the company," health minister told BBC TV

Moderna, Pfizer Covid-19 vaccines look strong: Here's how they stack up

The data will likely increase confidence that more vaccines will work and that the world may soon find a way to get the coronavirus under control

Moderna Covid-19 vaccine stability could give it edge over Pfizer's version

The vaccine is more stable than expected at temperatures that ordinary refrigerators can provide

Diwali brings hopes for economic revival

The spread of Covid-19 has been contained in most parts of our country

Covid-19 crisis: Normal life back likely next winter, says BioNTech CEO

BioNTech co-founder Uğur Şahin told BBC One's The Andrew Marr Show on Sunday: "this winter will be hard and the vaccine will not have a big impact on the infection numbers

Pfizer vaccine has 'extraordinarily high degree of efficacy': Fauci

A successful inoculation could be a key factor in overcoming reluctance to take pandemic vaccines that have been developed at top speed.

Coronavirus vaccine update: 20 mn Americans may get vaccine by December-end

The Russian 'Sputnik V' vaccine for Covid-19 has arrived in India for human clinical trial

Israel signs deal with Pfizer for potential 8 mn doses of Covid-19 vaccine

Pfizer's potential vaccine is likely to be a two-dose course of treatment

Coronavirus updates: 2nd wave in Maharashtra 'soon' & the vaccine challenge

The Maharashtra government has said that the the second wave of coronavirus is expected in the state in January-February based on what is happening in Europe

Covid-19 vaccines: Cold storage issues may hamper distribution, says Fauci

Anthony Fauci on Wednesday said it would be challenging to distribute vaccines that use messenger RNA based technology in developing countries

Europe to pay less than US for Pfizer vaccine under initial deal: Report

Under the EU deal, 27 European countries could buy 200 million doses, and have an option to purchase another 100 million

Pfizer CEO made $5.6 mn stock sale on same day as Covid-19 vaccine update

CEO Albert Bourla authorized the sale of the shares on Aug. 19, provided the stock was at least at a certain price, as part of a predetermined plan, the company said

Nasdaq rebounds as vaccine news raises hopes, focus returns to tech stocks

The tech-skewed Nasdaq advanced 1.5%, while technology mega-caps including Netflix Inc, Amazon.com Inc and Facebook Inc, the so-called stay-at-home winners, also gained between 1% and 2%.